BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Butaclamol Hydrochloride

A benzocycloheptapyridoisoquinolinol that has been used as an antipsychotic, especially in schizophrenia.

4+ PubMed studies analyzed · Evidence Score: 12.3

Research Domains

Butaclamol Hydrochloride has been studied across 3 research domains including 🧠 Learning, 😴 Sleep, 🫁 Liver & Detox. The primary research focus is 🧠 Learning with 25% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Butaclamol Hydrochloride, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Tomatine
5 shared targets
acivicin
4 shared targets
pyrrolnitrin
5 shared targets
Cetomacrogol
3 shared targets
Dihydrotachysterol
2 shared targets
Trabectedin
5 shared targets
Testolactone
2 shared targets
Prasugrel
3 shared targets
Loteprednol
3 shared targets
Doripenem
3 shared targets
Loading evidence profile...

This evidence profile for Butaclamol Hydrochloride is generated deterministically from 4 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.